Oxford Immunotec Global PLC

Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercialising proprietary tests for the management of undeserved immune-regulated conditions. The Company’s T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, U.K. and in Marlborough, MA.

Additional information can be found at www.oxfordimmunotec.com